MedTrace Logo

Prognostic Biomarkers in Patients With Acute Pericarditis

NCT02754713 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2016-04-28

No results posted yet for this study

Summary

The study will aim at investigating novel plasma or imaging biomarkers in patients with acute pericarditis. All participants will be treated according to established clinical recommendations for the diagnosis and treatment of acute pericarditis.

Study participants will undergo blood sampling for measurements of plasma biomarkers potentially involved in the pathogenesis of acute pericarditis. Imaging datasets from available imaging tests will be used to quantify imaging biomarkers. Patients will be followed up prospectively for up to 18 months. The prognostic value of plasma and/or imaging biomarkers for development of complications such as atrial fibrillation, pericarditis recurrences, constrictive pericarditis and/or the need to switch to 2nd line treatment will be sought.

Conditions

  • Pericarditis

Sponsors & Collaborators

  • Hippocration General Hospital

    lead OTHER

Principal Investigators

  • Dimitris Tousoulis, Professor · Cardiology Department, Hippokration Hospital, Athens Medical School

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02754713 on ClinicalTrials.gov